Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Abraxis Split Closes Door on a Rocky Patch for AstraZeneca
- The split between AstraZeneca and Abraxis over their copromotion of cancer drug Abraxane was expected among some Abraxis reps since August of this year. Now it's official. The end of the agreement comes as the patent on Casodex expires in April 2009 and the company this week saw mixed results...
- Blog posts 2008-11-26
Additional Resources
- Abraxis BioScience Files Information Statement in Connection with Its Announced Separation into Two Publicly Traded Companies
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced the filing of its Form 10 registration statement in connection with the proposed plan to separate its proprietary business -- Abraxis Oncology and Abraxis Research the new Abraxis BioScience -- from its hospital-based business -- Abraxis...
- Research articles 2007-08-10
- Abraxis to Appeal Jury Ruling on Elan Patent Infringement Claim
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced that it intends to appeal the jury ruling in the U.S. District Court for the District of Delaware that Abraxis has infringed upon a patent owned by Elan. In the suit, Elan claimed that Abraxis...
- Research articles 2008-06-13
- Abraxis BioScience to Present at the Bear Stearns Healthcare Conference
- LOS ANGELES, Calif. -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that Thomas Silberg, president of Abraxis Pharmaceutical Products, the company's hospital-based business, will present a company overview at the Bear Stearns Healthcare Conference on Tuesday, September 11, 2007 at 8:30 a.m. ET at the Grand...
- Research articles 2007-09-04
- Abraxis BioScience to Present at the JPMorgan Healthcare Conference
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that Patrick Soon-Shiong, M.D., chairman and chief executive officer of Abraxis BioScience, will present a company overview at the JPMorgan Healthcare Conference on Monday, January 8, 2007 at 3:30 p.m. PST at the Westin St. Francis...
- Research articles 2007-01-04
- Abraxis BioScience to Present at the Wachovia Small and Mid-Cap Healthcare Conference
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that management of Abraxis BioScience will present a company overview at the Wachovia Healthcare Conference on Wednesday, January 31, 2007 at 9:00 a.m. EST at the Langham Hotel in Boston.
- Research articles 2007-01-22
- Abraxis BioScience to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that Thomas Silberg, president of Abraxis Pharmaceutical Products, the company's hospital-based products division, will present a company overview at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Wednesday, February 7, 2007 at 8:40...
- Research articles 2007-01-29
- Abraxis BioScience Completes Acquisition of the AstraZeneca U.S. Branded Anesthetic and Analgesic Product Lines
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced it has completed its acquisition of the AstraZeneca (NYSE:AZN) U.S. branded anesthetic and analgesic injectable product portfolios. Abraxis will have agreements with most major Group Purchasing Organizations GPOs, representing the majority of U.S. hospitals, and will...
- Research articles 2006-06-28
- Abraxis Bioscience, Inc. Q1 2008 Earnings Call Transcript
- Earnings Call ExcerptAbraxis Bioscience, Inc. ABII Q1 2008 Earnings Call May 15, 2008 11:30 am ET Executives Daniel Saks – Vice President of Investor Relations and Corporate Communication Patrick Soon-Shiong, M.D. – Chairman and Chief Executive Officer Lisa Gopalakrishna – Chief Financial Officer Presentation Operator Good day ladies...
- Earnings calls 2008-05-15
- Abraxis BioScience Appoints David O'Toole as Chief Financial Officer
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABII), an integrated, global biotechnology company, today announced that David O'Toole has been appointed Executive Vice President and Chief Financial Officer, succeeding Lisa Gopala. Mr. O'Toole, 49, comes to Abraxis with 24 years of experience providing financial, consulting and international tax services to...
- Research articles 2008-05-28
- Abraxis BioScience and the California NanoSystems Institute Announce Partnership for Collaborative Research in the Development of New Nanobiotechnologies
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, and the California NanoSystems Institute at UCLA today announced a partnership designed to collaborate on early research in nanobiotechnology for the advancement of new technologies in medicine. Abraxis BioScience will collaborate with the CNSI and its team...
- Research articles 2007-07-26
- Abraxis BioScience to Present at the UBS Global Specialty Pharmaceutical Conference
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that the company's senior management team will present a company overview at the UBS Global Specialty Pharmaceuticals Conference on Tuesday, April 25, 2006 at 10:00 a.m. EDT at the Grand Hyatt New York.
- Research articles 2006-04-20
- Abraxis BioScience to Present at the Bank of America 2007 Health Care Conference
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that Patrick Soon-Shiong, M.D., chairman and chief executive officer, will present a company overview at the Bank of America 2007 Health Care Conference on Wednesday, May 30, 2007 at 2:00 p.m. PT at the Four Seasons...
- Research articles 2007-05-23
- Abraxis BioScience to Present at the Goldman Sachs Global Healthcare Conference
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that Patrick Soon-Shiong, M.D., the company's chairman and chief executive officer, will present a company overview at the Goldman Sachs 27th Annual Global Healthcare Conference on Wednesday, June 14, 2006 at 4:20 p.m. PDT at the...
- Research articles 2006-06-05
- Abraxis Bioscience Completes Acquisition of Manufacturing Complex from Pfizer
- State-of-the-Art Puerto Rico Facility Supplements Abraxis' Manufacturing Capabilities to Support Expansion of its Injectables Portfolio
- Research articles 2007-02-14
- Abraxis BioScience to Present at the Bank of America 2006 Health Care Conference
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that Patrick Soon-Shiong, M.D., the company's chairman and chief executive officer, will present a company overview at the Bank of America 2006 Health Care Conference on Wednesday, May 17, 2006 at 10:40 a.m. PDT at the...
- Research articles 2006-05-11
- Abraxis BioScience to Present at the UBS Global Life Sciences Conference
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that Patrick Soon-Shiong, M.D., the company's chairman and chief executive officer, will present a company overview at the UBS Global Life Sciences Conference on Thursday, September 28, 2006 at 8:30 a.m. ET at the Grand Hyatt...
- Research articles 2006-09-20
- Abraxis BioScience Receives FDA Tentative Approval for Fosphenytoin Sodium Injection, USP
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that it has received a tentative approval from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for Fosphenytoin Sodium Injection, 100 mg, 2 mL and 500 mg, 10 mL vials,...
- Research articles 2007-04-19
- Zacks Buy List Highlights: Abraxis BioScience, Inc., Lincoln Electric Holdings, Inc., Ezcorp Inc. and FirstFed Financial Corp
- CHICAGO -- Zacks.com releases the latest list of Zacks Rank Buy Stocks. Everyday on Zacks.com, four stocks are selected based on how well they match the criteria for the four main schools of investing: Aggressive Growth, Growth & Income, Momentum and Value. The four Zacks Rank Buy stocks highlighted today...
- Research articles 2006-07-06
- Abraxis BioScience Announces Co-Promotion Agreement with AstraZeneca for ABRAXANE® in the U.S. and the Acquisition of AstraZeneca's U.S. Branded Anesthetic and Analgesic Product Lines
- LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABBI):
- Research articles 2006-04-27
- << Previous
- page 1 of 1
- Next >>
Presented by American Express